Bio-Rad Laboratories, Inc., a leader in life science research and clinical diagnostics products, today announced that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jefferies Global Healthcare Conference 2026 June 3, 2026 8:45 AM EDTCompany ParticipantsRoop Lakkaraju - Executive VP ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The growth stock trade ...

Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2025-05-01. Here's what investors need to know before the announcement. Analysts estimate that Bio-Rad ...

With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry. The Hercules, California-based company develops and manufactures a wide range ...

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories, Inc. BIO and is expected to push the life-science tools and diagnostics company to improve its ...

On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing for changes to improve shareholder outcomes, focusing in part on the company’s ...

View Bio-Rad Laboratories, Inc. Class B BIO.B stock quote prices, financial information, real-time forecasts, and company news from CNN.

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24 ...

The stock price of Bio-Rad Laboratories (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 10% rise over the last twenty-one trading days, while it is up 30% ...